Stockreport

Immunomedics drug Trodelvy extends survival in breast cancer patients [Yahoo! Finance News]

IMMUNOMEDICS  (IMMU) 
Last immunomedics earnings: 2/27 04:00 pm Check Earnings Report
PDF By Manojna MaddipatlaSept 19 Reuters) - Immunomedics Inc's cancer drug Trodelvy, which received accelerated U.S. regulatory approval in April, extended survival time in [Read more]